The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: A systematic review

Obesity Surgery

Volumn 24, Issue 2, 2014, Pages 310-323

  Zechmeister Koss, Ingrid ^a   Huić, Mirjana ^b   Fischer, Stefan ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Agency for Quality and Accreditation in Health Care   (Croatia)

Author keywords

Duodenal jejunal bypass liner; Endoscopic techniques; Obesity; Type 2 diabetes mellitus

Indexed keywords

BODY MASS; DIGESTIVE SURGICAL DEVICE; DUODENAL JEJUNAL BYPASS LINER; GASTROINTESTINAL HEMORRHAGE; HUMAN; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; JEJUNUM; MALE; OBESITY; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84893710085     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1137-2     Document Type: Review

References (29)

1. World Health Organization. Obesity and overweight. Factsheet no. 311. Updated in March 2013. 2013 [cited 2013 August 18]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.html
2. International Diabetes Federation (IDF). IDF diabetes atlas 2013 [cited 2013 April 25]. Available from: http://www.idf.org/diabetesatlas/5e/diabetes
3. Elmadfa I, Hasenegger V, Wagner K, et al. Österreichischer Ernährungsbericht 2012. Vienna: Institut für Ernä hrungswissenschaften; 2012.
4. Hauner H, Buchholz G, Hamann B, et al. Prävention und Therapie der Adipositas 2007 [cited 2013 August 08]. Available from: http://www.dge.de/pdf/ ll/Adipositas-Leitlinie-2007.pdf
5. National Institute for Health and Clinical Excellence. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. London: National Institute for Health and Clinical Excellence; 2006.
6. Scottish Intercollegiate Guidelines Network. Management of obesity: a national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2010.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2013;36:S11-66.
8. Scottish Intercollegiate Guidelines Network. Management of diabetes. Edinburgh: Scottish Intercollegiate Guidelines Network; 2010.
9. The Royal College of Physicians. Type 2 diabetes. National clinical guideline for primary and secondary care (update). London: The Royal College of Physicians; 2008.
10. ECRI Institute. AHRQ health care horizon scanning system - potential high-impact interventions report. Priority area 10: obesity. (Prepared by ECRI Institute under Contract No. HHSA290201000006C.). Rockville: Agency for Healthcare Research and Quality; 2012.
11. National Institute for Health and Clinical Excellence. Bariatric surgical service for the treatment of people with severe obesity. Commissioning guide. London: National Institute for Health and Clinical Excellence; 2007.
12. National Institute for Health and Clinical Excellence. Interventional procedure overview of implantation of a duodenal-jejunal bypass sleeve for managing obesity. London: National Institute for Health and Clinical Excellence; 2012.
13. Australian Government: Department of Health and Ageing. Horizon scanning technology prioritising summary. In: EndoBarrier Gastrointestinal Liner for obesity. Series horizon scanning technology prioritising summary. Commonwealth of Australia; 2010. p. 10.
14. Gartlehner G. Internes manual. Abläufe und Methoden. Teil 2 (2nd Ed.). LBI-HTA Projektbericht 006 2008; (6):1-79.
15. European Network for Health Technology Assessment (EUnetHTA). Endpoints used for relative effectiveness assessment of pharmaceuticals: clinical endpoints. Copenhagen: EUnetHTA; 2013.
16. Bray G. Overview of therapy for obesity in adults 2013 [cited 2013 June 10]. Available from: http://www.uptodate.com/contents/overview-of-therapy-for- obesity-in-adults?source=search-result&search=obesity+treatment& selectedTitle=1%7E150#H11
17. Jackson E, Rubenfire M. Obesity, weight reduction, and cardiovascular disease 2012 [cited 2013 June 10]. Available from: http://www.uptodate.com/ contents/obesity-weight-reduction-and-cardiovascular-disease?source= search-result&search=voluntary+weight+loss&selectedTitle=6%7E150
18. Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res. 2004;4(1):38.
19. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71(6):976-82.
20. Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11(11):725-32.
21. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251(2):236-43.
22. Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23(3):650-6.
23. Cohen RV, Galvao Neto MP, Correa J, et al. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab. 2013;98(2):E279-82.
24. de Moura EGH, Orso IRB, Martins BC, et al. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg. 2011;21(7):941-7.
25. de Moura EGH, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther. 2012;14(2):183-9.
26. Escalona A, Yanez R, Pimentel F, et al. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis. 2010;6(2):126-31.
27. Escalona A, Pimentel F, Sharp A, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg. 2012;255(6):1080-5.
28. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4(1):55-9.
29. Patel SR, Hakim D, Mason J, et al. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surg Obes Relat Dis 2013;9:482-4.